Bulletin
Investor Alert

New York Markets Open in:

Centene Corp.

NYS: CNC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 14, 2020, 5:48 p.m.

CNC
/zigman2/quotes/208900023/composite

$

64.94

Change

0.00 0.00%

Volume

Volume 1.30m

Quotes are delayed by 20 min

/zigman2/quotes/208900023/composite

Previous close

$ 65.89

$ 64.94

Change

-0.95 -1.44%

Day low

Day high

$64.27

$65.88

Open

52 week low

52 week high

$41.62

$68.64

Open

Company Description

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs thr...

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Valuation

P/E Current

20.68

P/E Ratio (without extraordinary items)

20.02

Price to Sales Ratio

0.35

Price to Book Ratio

2.08

Price to Cash Flow Ratio

17.82

Enterprise Value to EBITDA

13.77

Enterprise Value to Sales

0.51

Total Debt to Enterprise Value

0.34

Efficiency

Total Asset Turnover

2.08

Liquidity

Current Ratio

1.49

Profitability

Operating Margin

2.86

Pretax Margin

2.39

Net Margin

1.77

Return on Assets

3.67

Return on Equity

11.26

Return on Total Capital

9.69

Return on Invested Capital

6.04

Capital Structure

Total Debt to Total Equity

109.36

Total Debt to Total Capital

52.24

Total Debt to Total Assets

33.48

Long-Term Debt to Equity

108.66

Long-Term Debt to Total Capital

51.90

Officers and Executives

Name Age Officer Since Title
Mr. Michael F. Neidorff 76 1996 Chairman, President & Chief Executive Officer
Mr. Jeffrey A. Schwaneke 43 2008 Chief Accounting Officer, VP & Controller
Dr. Ken Yamaguchi - 2015 Chief Medical Officer & Executive Vice President
Mr. Mark J. Brooks 49 2016 Chief Information Officer & Senior Vice President
Dr. Mary V. Mason 50 2006 Chief Medial Officer & Senior Vice President

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/06/2020 Robert K. Ditmore
Director
30,000   Disposition at $65.31 per share. 1,959,300
02/06/2020 Tommy George Thompson
Director
500   Disposition at $65.81 per share. 32,905
02/04/2020 Michael F. Neidorff
Chairman, President & CEO; Director
190,090   Derivative/Non-derivative trans. at $62.88 per share. 11,952,859
02/04/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
29,728   Derivative/Non-derivative trans. at $62.88 per share. 1,869,296
02/04/2020 Jeffrey A. Schwaneke
EVP, CFO
33,957   Derivative/Non-derivative trans. at $62.88 per share. 2,135,216
02/04/2020 Brandy Burkhalter
EVP, Operations
16,997   Derivative/Non-derivative trans. at $62.88 per share. 1,068,771
02/04/2020 Mark J. Brooks
EVP, Chief Information Officer
14,624   Derivative/Non-derivative trans. at $62.88 per share. 919,557
02/04/2020 Keith H. Williamson
EVP, Secr. & General Counsel
12,767   Derivative/Non-derivative trans. at $62.88 per share. 802,788
02/04/2020 Christopher R. Isaak
SVP, Corporate Controller, CAO
6,106   Derivative/Non-derivative trans. at $62.88 per share. 383,945
02/04/2020 Michael F. Neidorff
Chairman, President & CEO; Director
156,600   Award at $28.51 per share. 4,464,666
02/04/2020 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
24,360   Award at $28.13 per share. 685,246
02/04/2020 Jeffrey A. Schwaneke
EVP, CFO
27,840   Award at $28.13 per share. 783,139
02/04/2020 Brandy Burkhalter
EVP, Operations
13,920   Award at $28.13 per share. 391,569
02/04/2020 Mark J. Brooks
EVP, Chief Information Officer
13,920   Award at $28.13 per share. 391,569
02/04/2020 Keith H. Williamson
EVP, Secr. & General Counsel
10,440   Award at $28.13 per share. 293,677
02/04/2020 Christopher R. Isaak
SVP, Corporate Controller, CAO
4,949   Award at $28.13 per share. 139,215
01/23/2020 Kenneth A. Burdick
EVP, Markets & Products
65,907   Award at $66.76 per share. 4,399,951
01/23/2020 Kenneth A. Burdick
EVP, Markets & Products
920,408   Award at $0 per share. 0
01/23/2020 David L. Steward
Director
10   Award at $0 per share. 0
01/23/2020 William L. Trubeck
Director
775   Award at $66.76 per share. 51,739
01/23/2020 William L. Trubeck
Director
81,339   Award at $0 per share. 0
01/23/2020 H. James Dallas
Director
775   Award at $66.76 per share. 51,739
01/23/2020 H. James Dallas
Director
15,644   Award at $0 per share. 0
01/02/2020 Tommy George Thompson
Director
500   Disposition at $62.98 per share. 31,490
12/31/2019 Robert K. Ditmore
Director
783   Award at $54.25 per share. 42,477
12/31/2019 Tommy George Thompson
Director
645   Award at $54.25 per share. 34,991
12/31/2019 John R. Roberts
Director
576   Award at $54.25 per share. 31,248
12/31/2019 Frederick H. Eppinger
Director
576   Award at $54.25 per share. 31,248
12/31/2019 David L. Steward
Director
645   Award at $54.25 per share. 34,991
12/26/2019 Mark J. Brooks
EVP, Chief Information Officer
2,947   Disposition at $63.34 per share. 186,662
12/19/2019 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
1,074   Derivative/Non-derivative trans. at $60.35 per share. 64,815
12/17/2019 Robert K. Ditmore
Director
30,000   Disposition at $59.49 per share. 1,784,700
12/17/2019 Keith H. Williamson
EVP, Secr. & General Counsel
11,000   Disposition at $59.13 per share. 650,430
12/14/2019 Michael F. Neidorff
Chairman, President & CEO; Director
25,440   Derivative/Non-derivative trans. at $57.71 per share. 1,468,142
12/13/2019 Michael F. Neidorff
Chairman, President & CEO; Director
19,094   Derivative/Non-derivative trans. at $58.52 per share. 1,117,380
12/13/2019 Jesse N. Hunter
EVP, M&A & Chief Strategy Ofcr
4,177   Derivative/Non-derivative trans. at $58.52 per share. 244,438
12/13/2019 Jeffrey A. Schwaneke
EVP, CFO
4,774   Derivative/Non-derivative trans. at $58.52 per share. 279,374
12/13/2019 Brandy Burkhalter
EVP, Operations
2,387   Derivative/Non-derivative trans. at $58.52 per share. 139,687
12/13/2019 Mark J. Brooks
EVP, Chief Information Officer
2,387   Derivative/Non-derivative trans. at $58.52 per share. 139,687
12/13/2019 Keith H. Williamson
EVP, Secr. & General Counsel
1,696   Derivative/Non-derivative trans. at $58.52 per share. 99,249
12/13/2019 Christopher R. Isaak
SVP, Corporate Controller, CAO
849   Derivative/Non-derivative trans. at $58.52 per share. 49,683
/news/latest/company/us/cnc

MarketWatch News on CNC

  1. 8 Stocks Wall Street Loves for Valentine's Day

    12:59 p.m. Feb. 13, 2020

    - Barron's Online

  2. Why Netflix Needs Those Oscar Nominations

    9:30 p.m. Jan. 31, 2020

    - Barron's Online

  3. Paycom set to join S&P 500

    5:36 p.m. Jan. 22, 2020

    - Max A. Cherney

  4. The Case for ‘Cash Cows’ Like Alphabet, Ford, and Facebook

    12:16 p.m. Jan. 22, 2020

    - Barron's Online

  5. 3 Managed-Care Stocks to Buy on Medicaid Fears

    10:11 a.m. Jan. 21, 2020

    - Barron's Online

  6. Stocks Are Going Nowhere as Hope for a Trade Deal Wavers

    10:12 a.m. Nov. 19, 2019

    - Barron's Online

  7. Centene stock price target raised to $77 from $72 at SunTrust RH

    7:58 a.m. Nov. 18, 2019

    - Tomi Kilgore

  8. The Dow Is Down 25 Points as Investors Wait for the Fed

    11:29 a.m. Oct. 30, 2019

    - Barron's Online

  9. Here are Wall Street’s favorite value stocks

    9:25 a.m. Oct. 26, 2019

    - Philip van Doorn

  10. Loading more headlines...
/news/nonmarketwatch/company/us/cnc

Other News on CNC

  1. Tracking Dan Loeb's Third Point Portfolio - Q4 2019 Update

    10:05 p.m. Feb. 17, 2020

    - Seeking Alpha

  2. FPA Capital Fund, Inc. Q4 2019 Commentary

    8:15 a.m. Feb. 17, 2020

    - Seeking Alpha

  3. The Best Stocks To Buy Now

    6:46 p.m. Feb. 16, 2020

    - Seeking Alpha

  4. Income and Growth Investors Will Benefit as CVS Adopts Managed Care

    6:30 a.m. Feb. 14, 2020

    - InvestorPlace.com

  5. CVS Q4 beat buoys health insurers

    11:12 a.m. Feb. 12, 2020

    - Seeking Alpha

  6. Molina Healthcare's (MOH) Q4 Earnings Surpass, Decline Y/Y

    10:38 a.m. Feb. 11, 2020

    - Zacks.com

  7. JPMorgan likes Centene in premarket analyst action

    7:50 a.m. Feb. 5, 2020

    - Seeking Alpha

  8. Centene’s Profit Dented by Higher Costs

    4:35 p.m. Feb. 4, 2020

    - Dave Sebastian

  9. Centene's (CNC) Q4 Earnings Miss Estimates, Improve Y/Y

    11:32 a.m. Feb. 4, 2020

    - Zacks.com

  10. Centene slips 2% after higher-than-expected medical costs in Q4

    10:39 a.m. Feb. 4, 2020

    - Seeking Alpha

  11. Centene (CNC) Gets a Buy Rating from Oppenheimer

    8:12 a.m. Feb. 4, 2020

    - SmarterAnalyst

  12. Centene (CNC) Q4 Earnings Miss Estimates

    7:30 a.m. Feb. 4, 2020

    - Zacks.com

  13. Centene Q4 top line up 14%; non-GAAP EPS up 6%

    7:13 a.m. Feb. 4, 2020

    - Seeking Alpha

  14. Notable earnings before Tuesday's open

    5:30 p.m. Feb. 3, 2020

    - Seeking Alpha

  15. Centene Q4 2019 Earnings Preview

    5:30 p.m. Feb. 3, 2020

    - Seeking Alpha

  16. Loading more headlines...

At a Glance

Centene Corp.

Centene Plaza

7700 Forsyth Boulevard

St. Louis, Missouri 63105

Phone

1 3147254477

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$74.64B

Net Income

$1.32B

2019 Sales Growth

24.2%

Employees

-

/news/pressrelease/company/us/cnc

Press Releases on CNC

  1. Loading more headlines...
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.